Live
- BJP releases ‘charge sheet’ against BJD govt
- District Nodal Officer Venkataramana announced the intermediate results
- She team that stopped child marriages
- Medical devices sector needs separate rules, says industry body AiMeD
- Andhra Paper declares lockout
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
Dr Reddy's inks marketing pact with Biocodex
City-based Dr Reddy\'s Laboratories on Wednesday said it signed a strategic agreement with Biocodex, a Paris-based specialty pharmaceutical company, to market and distribute latter’s products in the Romanian Market.
Hyderabad: City-based Dr Reddy's Laboratories on Wednesday said it signed a strategic agreement with Biocodex, a Paris-based specialty pharmaceutical company, to market and distribute latter’s products in the Romanian Market.
Biocodex has a diverse product portfolio, covering gastroenterology, pain management, neurology, rheumatology, among other therapeutic areas. Its products are marketed in over 100 countries through a network of wholly owned subsidiaries, licensees, distributors and licensed retailers.
"Biocodex has announced the change in partnership and effective October 1, 2015, Dr Reddy's has been given the complete rights for promotion and distribution of the Biocodex products across Romania. Earlier, AKACIA was in partnership with Biocodex for a similar distribution pact," Dr Reddy's said in a statement.
With this new marketing deal, it will aim to develop the access off Romanian patients to the prescription portfolio including Biocodex's well-known OTC products, Enterol and Otipax.
